Dr. Sarah Cecilia Sorice, MD

Dr. Sorice practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Sorice's NPI, 1780940262, was assigned on April 9, 2012. Dr. Sorice graduated from New York University School of Medicine in 2012. Dr. Sorice holds California license A127162.

Dr. Sorice's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Sorice's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Sorice is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Sorice to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Sorice's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sorice practices, 6 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Sorice's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Sorice is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Sorice's licenses on file in 4 states: California, Florida, New Jersey and Pennsylvania.

Dmand AI lists breast reconstruction and breast surgery among the conditions Dr. Sorice treats.

CMS data shows 34 Medicare services from Dr. Sorice across 1 procedure code in 2024, all of them office visits, for 50 Medicare patients. Medicare paid $6,187 for them. Every service was in an office.

CMS counts 50 Medicare patients who saw Dr. Sorice in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sorice's median patient age at 54, with 94% women.

In 2024, Dr. Sorice wrote 25 Medicare Part D claims. 96% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $98 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Sorice for performance year 2024, reported as part of a group. Dr. Sorice accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sorice as offering telehealth. CMS counts 51 procedures of mastectomy by Dr. Sorice, more than 95% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Sorice, published from 2013 to 2019. The most frequent topics are Free Tissue Flaps, Mammaplasty and Surgery, Plastic. Dr. Sorice has published most often in Plast Reconstr Surg. Dr. Sorice's most frequent co-authors are Alexander J. Li, Arash Momeni, MD and Francisco L. Canales, MD.

CMS Open Payments shows 51 general payments to Dr. Sorice from 13 drug and device companies from 2021 to 2025. Honoraria make up the largest share, 40% of the total. Rti Surgical, Inc paid the most, $27,265.

Dr. Sorice graduated from New York University School of Medicine in 2012.

Dr. Sorice is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.